Adamis and La Jolla Pharmaceutical to merge
This article was originally published in Scrip
Executive Summary
Adamis Pharmaceuticals has entered a merger agreement to acquire fellow US firm La Jolla Pharmaceutical Company. The deal has been approved by both boards of directors and, subject to closing conditions including shareholder approval, is expected to close in the first quarter of next year.